Donate Now
  • What We're Working On
Inflammatory Arthritis Prevention and Treatment in Indigenous Communities
arc_placeholder_new
Scientific Study Title:
Indigenous Inflammatory Arthritis Prevention and Treatment approaches for Health Equity (IIA-PATH)
Start Date:
  • 2025
End Date:
  • 2030
Research Category
Tags

Why do this research?

Inflammatory forms of arthritis, some of which include rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis are chronic, autoimmune diseases. Inflammatory arthritis occurs at a higher rate in Indigenous Peoples compared to the general population, and people from Indigenous communities face increased barriers to accessing care.

Currently, we do not have enough information to know who is at risk of developing inflammatory arthritis. This project will focus on improving our prediction and understanding of inflammatory arthritis risk in people from Indigenous communities by looking at factors like genetics, immune system health, the environment, and social conditions. It will also take a patient-centred approach to help guide and create treatment choices that meet the holistic health needs of Indigenous patients.

What will be done?

This project will have two parts. First, we will focus on screening people from Indigenous communities to understand their risk of inflammatory arthritis. This will focus on addressing genetic, environmental, and social triggers of inflammatory arthritis. We will include people from rural and urban communities, of all ages and genders.

Next, we will focus on understanding how to provide culturally appropriate care for Indigenous people who already have inflammatory arthritis. We will aim to create care plans informed by persons from Indigenous communities that reflect the needs and traditions of Indigenous communities, including:

  • Helping patients make treatment decisions through shared decision-making, where both the doctor and patient work together.
  • Providing support and health system navigation for patients through an Arthritis Liaison resource
  • Offering peer support activities and community programs focused on arthritis wellness, determined by partner communities.

The Research Team

Principal Investigators

  • Cheryl Barnabe, (https://arthritisresearch.ca/cheryl-barnabe/) MD, MSc, FRCPC , Senior Scientist, Arthritis Research Canada (University of Calgary)
  • Terri-Lynn Fox (Mount Royal University)
  • Stephanie Montesanti (University of Alberta)
  • Liam O’Neil (University of Manitoba)
  • Pamela Roach (University of Calgary)

Co-Investigators

  • Claire Barber, MD, PhD, FRCPC , Research Scientist, Arthritis Research Canada (University of Calgary)
  • Hani El-Gabalawy (University of Manitoba)
  • Glen Hazlewood, MD, PhD, FRCPC , Research Scientist, Arthritis Research Canada (University of Calgary)
  • Diane Lacaille, Scientific Director, Arthritis Research Canada, (University of British Columbia)
  • Jordi Pardo Pardo (Cochrane Equity Thematic Group)
  • Karine Toupin-April, MD, (University of Ottawa)

Who Funded This Research?

Canadian Institutes of Health Research

How Can People Get Involved?

This project includes many community collaborators, including:

  • Siksika First Nation (represented by Cheryl Sorenson, Siksika Nation Home Care Team leader and Charlene Brough, Siksika Nation Nursing Advisor and Community Paramedic Team leader)
  • Kainai First Nation (represented by Dr. Terri-Lynn Fox, a person living with rheumatoid arthritis, and Director of the Wellness Program, Blood Tribe Dept. of Health
  • Elbow River Healing Lodge, an urban Indigenous clinic in downtown Calgary (represented by Danene Lenstra, Manager)
  • Otipemisiwak Metis government (represented by Reagan Bartel, Director of Health)

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More